Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Accenture
Medtronic
Fuji
Harvard Business School

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 8,900,565

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,900,565
Title:Indole derivatives as inhibitors of histone deacetylase
Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of histone deacetylase 8 (HDAC8). Also described herein are methods of using such HDAC8 inhibitors, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of HDAC8 activity.
Inventor(s): Buggy; Joseph J. (Moutain View, CA), Balasubramanian; Sriram (San Carlos, CA), Verner; Erik (San Mateo, CA), Tai; Vincent W. F. (San Mateo, CA), Lee; Chang-Sun (Belle Mead, NJ)
Assignee: Pharmacyclics, Inc. (Sunnyvale, CA)
Application Number:13/683,880
Patent Claims:see list of patent claims

Details for Patent 8,900,565

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Pharmacyclics, Inc. (Sunnyvale, CA) 2026-03-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Pharmacyclics, Inc. (Sunnyvale, CA) 2026-03-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Pharmacyclics, Inc. (Sunnyvale, CA) 2026-03-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Pharmacyclics, Inc. (Sunnyvale, CA) 2026-03-16 RX search
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; SINGLE-USE 103234 001 1989-06-01 ➤ Sign Up Pharmacyclics, Inc. (Sunnyvale, CA) 2026-03-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
AstraZeneca
Citi
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.